Early research (Phase 1)WithdrawnNCT04372641
What this trial is testing
Testing the Safety of CB-5339 in Patients With Cancer
Who this might be right for
Aggressive Non-Hodgkin LymphomaIndolent Non-Hodgkin LymphomaLocally Advanced Malignant Solid Neoplasm+1 more
National Cancer Institute (NCI)